Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 16596327)

1.

Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York.

Gaudet MM, Bensen JT, Schroeder J, Olshan AF, Terry MB, Eng SM, Teitelbaum SL, Britton JA, Lehman TA, Neugut AI, Ambrosone CB, Santella RM, Gammon MD.

Breast Cancer Res Treat. 2006 Sep;99(2):235-40. Epub 2006 Apr 5.

PMID:
16596327
2.

Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk.

Gaudet MM, Chanock S, Lissowska J, Berndt SI, Peplonska B, Brinton LA, Welch R, Yeager M, Bardin-Mikolajczak A, Garcia-Closas M.

Cancer Res. 2006 Oct 1;66(19):9781-5.

3.

Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.

Wang SS, Morton LM, Bergen AW, Lan EZ, Chatterjee N, Kvale P, Hayes RB, Chanock SJ, Caporaso NE.

Hum Genet. 2007 Aug;122(1):41-9. Epub 2007 May 12.

PMID:
17497175
4.

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.

Kocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J, Noro M, Oswald P, Souery D, Zohar J, Massat I.

Int Clin Psychopharmacol. 2010 Jul;25(4):218-27. doi: 10.1097/YIC.0b013e328338b884.

PMID:
20531207
5.

Association of COMT haplotypes and breast cancer risk in caucasian women.

Peterson NB, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Huang Y, Chanock SJ, Haines JL, Egan KM.

Anticancer Res. 2010 Jan;30(1):217-20.

6.

The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.

Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Tan EK, Drozdzik M.

Pharmacogenet Genomics. 2008 Sep;18(9):815-21. doi: 10.1097/FPC.0b013e328306c2f2.

PMID:
18698234
7.

Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms.

Ji Y, Olson J, Zhang J, Hildebrandt M, Wang L, Ingle J, Fredericksen Z, Sellers T, Miller W, Dixon JM, Brauch H, Eichelbaum M, Justenhoven C, Hamann U, Ko Y, Brüning T, Chang-Claude J, Wang-Gohrke S, Schaid D, Weinshilboum R.

Cancer Res. 2008 Jul 15;68(14):5997-6005. doi: 10.1158/0008-5472.CAN-08-0043.

8.

Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study.

Wedrén S, Lovmar L, Humphreys K, Magnusson C, Melhus H, Syvänen AC, Kindmark A, Landegren U, Fermér ML, Stiger F, Persson I, Baron J, Weiderpass E.

Breast Cancer Res. 2004;6(4):R437-49. Epub 2004 Jun 4.

9.

Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer.

Yim DS, Parkb SK, Yoo KY, Yoon KS, Chung HH, Kang HL, Ahn SH, Noh DY, Choe KJ, Jang IJ, Shin SG, Strickland PT, Hirvonen A, Kang D.

Pharmacogenetics. 2001 Jun;11(4):279-86.

PMID:
11434504
10.

An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.

Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW, Yager JD.

Cancer Res. 1997 Dec 15;57(24):5493-7.

11.

Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk.

Reding KW, Weiss NS, Chen C, Li CI, Carlson CS, Wilkerson HW, Farin FM, Thummel KE, Daling JR, Malone KE.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1461-7. doi: 10.1158/1055-9965.EPI-08-0917. Epub 2009 Apr 21.

12.

Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer.

Udler MS, Azzato EM, Healey CS, Ahmed S, Pooley KA, Greenberg D, Shah M, Teschendorff AE, Caldas C, Dunning AM, Ostrander EA, Caporaso NE, Easton D, Pharoah PD.

Int J Cancer. 2009 Dec 1;125(11):2687-96. doi: 10.1002/ijc.24678.

PMID:
19551860
13.

Effect of catechol-o-methyltransferase-gene (COMT) variants on experimental and acute postoperative pain in 1,000 women undergoing surgery for breast cancer.

Kambur O, Kaunisto MA, Tikkanen E, Leal SM, Ripatti S, Kalso EA.

Anesthesiology. 2013 Dec;119(6):1422-33. doi: 10.1097/ALN.0000000000000013.

PMID:
24343288
14.

Polymorphic catechol-O-methyltransferase gene and breast cancer risk.

Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Kang D, Vainio H, Uusitupa M, Hirvonen A.

Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):635-40.

15.

Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.

Gaudet MM, Chanock S, Lissowska J, Berndt SI, Yang XR, Peplonska B, Brinton LA, Welch R, Yeager M, Bardin-Mikolajczak A, Sherman ME, Sutter TR, Garcia-Closas M.

Pharmacogenet Genomics. 2006 Aug;16(8):547-53.

PMID:
16847423
16.

Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan.

Hamajima N, Matsuo K, Tajima K, Mizutani M, Iwata H, Iwase T, Miura S, Oya H, Obata Y.

Int J Clin Oncol. 2001 Feb;6(1):13-8.

PMID:
11706521
17.
18.

Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain.

Rakvåg TT, Ross JR, Sato H, Skorpen F, Kaasa S, Klepstad P.

Mol Pain. 2008 Dec 18;4:64. doi: 10.1186/1744-8069-4-64.

19.

Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin, and catechol-O-methyltransferase genes and non-Hodgkin lymphoma risk.

Skibola CF, Bracci PM, Paynter RA, Forrest MS, Agana L, Woodage T, Guegler K, Smith MT, Holly EA.

Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2391-401.

20.

Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk.

Wedrén S, Rudqvist TR, Granath F, Weiderpass E, Ingelman-Sundberg M, Persson I, Magnusson C.

Carcinogenesis. 2003 Apr;24(4):681-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk